Last 48 quarters of trend data · Healthcare · Medical - Distribution
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Prestige Consumer Healthcare Inc.'s quarterly P/E stands at 13.1x, down 39.0% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 17.3% YoY to 11.4x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 11.63 | 13.11 | 15.90 | 18.14 | 21.01 | 21.49 | 16.00 | 16.54 | 17.56 | 18.51 | 14.44 | 13.36 | 14.02 |
| — | -39.0% | -0.6% | +9.7% | +19.6% | +16.1% | +10.8% | +23.8% | +25.3% | — | -4.0% | +9.4% | +3.9% | |
| P/S Ratio | 1.98 | 2.51 | 2.62 | 2.80 | 3.99 | 3.63 | 3.36 | 3.18 | 3.24 | 3.29 | 2.71 | 2.50 | 2.67 |
| — | -30.8% | -22.2% | -11.8% | +23.1% | +10.1% | +23.9% | +27.1% | +21.3% | +20.8% | -4.8% | +15.5% | -0.8% | |
| P/B Ratio | 1.17 | 1.50 | 1.62 | 1.68 | 2.14 | 2.35 | 2.18 | 2.08 | 2.06 | 2.21 | 1.92 | 1.86 | 2.02 |
| — | -36.2% | -25.7% | -19.1% | +4.1% | +6.4% | +13.9% | +11.6% | +2.2% | +2.3% | +2.9% | +20.6% | +7.1% | |
| P/FCF | 8.47 | 15.56 | 9.85 | 13.88 | 12.73 | 18.44 | 15.36 | 13.30 | 16.13 | 14.31 | 11.04 | 12.03 | 16.00 |
| — | -15.6% | -35.9% | +4.4% | -21.1% | +28.8% | +39.1% | +10.5% | +0.8% | +3.6% | -25.3% | +6.0% | +22.7% | |
| EV / EBITDA | 9.21 | 11.35 | 11.05 | 11.44 | 15.37 | 13.72 | 12.34 | 12.83 | 14.12 | 13.18 | 11.16 | 10.65 | 11.49 |
| — | -17.3% | -10.5% | -10.8% | +8.8% | +4.1% | +10.6% | +20.5% | +22.9% | — | -5.5% | +0.5% | -1.4% | |
| EV / EBIT | 10.14 | 12.61 | 13.74 | 12.62 | 16.96 | 15.50 | 13.32 | 13.74 | 15.83 | 14.36 | 12.24 | 11.60 | 12.33 |
| — | -18.6% | +3.2% | -8.2% | +7.1% | +7.9% | +8.8% | +18.5% | +28.3% | — | -6.4% | -1.2% | -4.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Prestige Consumer Healthcare Inc.'s operating margin was 26.8% in Q4 2026, down 2.3 pp QoQ and down 3.0 pp YoY. The trailing four-quarter average of 28.4% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 15.5% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.8% | 50.0% | 55.5% | 56.2% | 54.2% | 59.2% | 55.5% | 55.5% | 54.7% | 54.8% | 55.9% | 55.9% | 55.4% |
| — | -15.5% | +0.1% | +1.3% | -0.9% | +8.0% | -0.7% | -0.7% | -1.3% | +1.9% | +2.3% | +0.4% | -4.2% | |
| Operating Margin | 28.4% | 26.8% | 29.1% | 29.1% | 28.8% | 29.8% | 31.7% | 29.7% | 27.0% | 29.7% | 30.7% | 30.8% | 30.5% |
| — | -10.0% | -8.1% | -2.3% | +6.6% | +0.5% | +3.1% | -3.5% | -11.6% | +130.2% | -2.9% | +5.7% | -2.9% | |
| Net Margin | 17.5% | 19.1% | 16.5% | 15.4% | 19.0% | 16.9% | 21.0% | 19.2% | 18.4% | 17.9% | 18.8% | 18.7% | 19.1% |
| — | +13.4% | -21.6% | -19.7% | +3.6% | -5.4% | +12.1% | +2.5% | -3.7% | +121.2% | -0.5% | +6.1% | -4.4% |
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.2% | 2.9% | 2.6% | 2.3% | 2.6% | 2.8% | 3.5% | 3.2% | 2.9% | 3.0% | 3.4% | 3.6% | 3.6% |
| — | +4.9% | -26.3% | -28.0% | -12.6% | -8.9% | +2.5% | -10.3% | -19.2% | +119.8% | +7.6% | +11.5% | +4.1% | |
| ROA | 5.5% | 1.5% | 1.3% | 1.2% | 1.4% | 1.5% | 1.8% | 1.6% | 1.5% | 1.5% | 1.6% | 1.6% | 1.6% |
| — | +2.8% | -26.7% | -25.2% | -6.2% | +0.2% | +15.5% | +2.4% | -6.9% | +121.9% | +13.7% | +15.7% | +5.8% | |
| ROIC | 8.2% | 2.0% | 2.2% | 2.2% | 1.9% | 2.4% | 2.5% | 2.3% | 2.0% | 2.2% | 2.4% | 2.4% | 2.3% |
| — | -17.2% | -11.7% | -5.8% | -1.2% | +6.7% | +5.9% | -4.0% | -15.1% | +130.9% | +10.2% | +15.5% | +8.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Prestige Consumer Healthcare Inc.'s Debt/EBITDA ratio is 12.5x, up from 12.0x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 15.1% YoY to 3.57x, tightening the short-term liquidity position.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.55 | 0.59 | 0.57 | 0.56 | 0.57 | 0.57 | 0.61 | 0.66 | 0.69 | 0.76 | 0.83 | 0.90 |
| — | -2.7% | +2.7% | -6.9% | -14.4% | -17.4% | -24.2% | -26.5% | -27.3% | -27.1% | -11.7% | -7.8% | -4.7% | |
| Debt / EBITDA | 3.07 | 12.47 | 11.98 | 11.92 | 13.13 | 10.91 | 10.39 | 11.80 | 13.76 | 12.66 | 12.84 | 13.34 | 14.40 |
| — | +14.2% | +15.3% | +1.0% | -4.6% | -13.8% | -19.1% | -11.6% | -4.5% | — | -15.4% | -15.6% | -8.4% | |
| Current Ratio | 3.57 | 3.57 | 3.11 | 3.70 | 4.38 | 4.20 | 3.68 | 3.56 | 3.23 | 3.20 | 3.09 | 2.99 | 2.66 |
| — | -15.1% | -15.6% | +3.8% | +35.6% | +31.2% | +19.0% | +19.0% | +21.5% | +31.5% | +21.1% | +35.4% | +27.3% | |
| Quick Ratio | 2.25 | 2.25 | 1.93 | 2.51 | 2.99 | 2.82 | 2.20 | 2.10 | 1.90 | 2.02 | 1.92 | 1.75 | 1.51 |
| — | -20.1% | -12.1% | +19.7% | +57.2% | +39.6% | +14.4% | +20.0% | +26.0% | +41.3% | +23.1% | +35.8% | +22.7% | |
| Interest Coverage | 7.31 | 6.61 | 6.79 | 7.89 | 7.05 | 7.87 | 8.00 | 6.84 | 5.45 | 5.41 | 5.20 | 5.00 | 4.88 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PBH stock.
Prestige Consumer Healthcare Inc.'s current P/E is 11.6x. The average P/E over the last 4 quarters is 17.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Prestige Consumer Healthcare Inc.'s current operating margin is 28.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Prestige Consumer Healthcare Inc.'s business trajectory between earnings reports.